Thrivent Financial for Lutherans’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-300,000
| Closed | -$974K | – | 2363 |
|
2019
Q4 | $974K | Buy |
+300,000
| New | +$974K | ﹤0.01% | 1508 |
|
2019
Q3 | – | Sell |
-118,046
| Closed | -$371K | – | 2291 |
|
2019
Q2 | $371K | Buy |
+118,046
| New | +$371K | ﹤0.01% | 1959 |
|
2017
Q2 | – | Sell |
-969,050
| Closed | -$2.2M | – | 2138 |
|
2017
Q1 | $2.2M | Buy |
+969,050
| New | +$2.2M | 0.01% | 812 |
|
2016
Q4 | – | Sell |
-240,320
| Closed | -$805K | – | 2066 |
|
2016
Q3 | $805K | Buy |
+240,320
| New | +$805K | ﹤0.01% | 1227 |
|
2014
Q2 | – | Sell |
-314,303
| Closed | -$2.61M | – | 1775 |
|
2014
Q1 | $2.61M | Sell |
314,303
-353,925
| -53% | -$2.94M | 0.02% | 537 |
|
2013
Q4 | $5.64M | Sell |
668,228
-374,200
| -36% | -$3.16M | 0.03% | 412 |
|
2013
Q3 | $8.31M | Buy |
1,042,428
+208,328
| +25% | +$1.66M | 0.05% | 341 |
|
2013
Q2 | $6.44K | Buy |
+834,100
| New | +$6.44K | 0.04% | 387 |
|